We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBIO
1151
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$185K ﹤0.01%
6,500
INSG icon
1152
Inseego
INSG
$86.3M
$185K ﹤0.01%
28,700
+7,500
+35% +$60K
FTK icon
1153
Flotek Industries
FTK
$1.32B
$183K ﹤0.01%
41,617
SPRB
1154
Spruce Biosciences
SPRB
$128M
$183K ﹤0.01%
1,133
ISPO
1155
DELISTED
Inspirato
ISPO
$181K ﹤0.01%
9,250
+3,750
+68% +$67.6K
VIRC icon
1156
Virco
VIRC
$95.2M
$181K ﹤0.01%
43,400
HYFM icon
1157
Hydrofarm Holdings
HYFM
$8.77M
$180K ﹤0.01%
23,000
+7,000
+44% +$83.6K
USIO icon
1158
Usio Inc
USIO
$63.7M
$179K ﹤0.01%
96,400
+45,000
+88% +$87.4K
HCWB icon
1159
HCW Biologics
HCWB
$5.45M
$179K ﹤0.01%
344
ARAV
1160
DELISTED
Aravive, Inc. Common Stock
ARAV
$179K ﹤0.01%
142,200
+50,000
+54% +$81.1K
JOAN
1161
DELISTED
JOANN, Inc. Common Stock
JOAN
$179K ﹤0.01%
205,000
+125,000
+156% +$185K
USCB icon
1162
USCB Financial Holdings
USCB
$410M
$179K ﹤0.01%
+17,500
New +$172K
CVGI icon
1163
Commercial Vehicle Group
CVGI
$148M
$178K ﹤0.01%
16,000
-26,400
-62% -$240K
CRD.A icon
1164
Crawford & Co Class A
CRD.A
$625M
$177K ﹤0.01%
16,001
+186
+1% +$1.79K
VIRX
1165
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$176K ﹤0.01%
125,000
RGS icon
1166
Regis Corp
RGS
$71.9M
$175K ﹤0.01%
7,895
+670
+9% +$14.4K
CAMP
1167
DELISTED
CalAmp Corp.
CAMP
$175K ﹤0.01%
7,177
+3,699
+106% +$180K
TXMD icon
1168
TherapeuticsMD
TXMD
$24.2M
$173K ﹤0.01%
42,000
SDPI
1169
DELISTED
Superior Drilling Products Inc.
SDPI
$172K ﹤0.01%
139,900
NXTC icon
1170
NextCure
NXTC
$22.7M
$170K ﹤0.01%
7,883
CNTX icon
1171
Context Therapeutics
CNTX
$46.3M
$169K ﹤0.01%
105,809
BHIL
1172
DELISTED
Benson Hill, Inc.
BHIL
$169K ﹤0.01%
+3,714
New +$159K
EEX
1173
DELISTED
Emerald Holding
EEX
$168K ﹤0.01%
41,000
BZFD icon
1174
BuzzFeed
BZFD
$94.1M
$168K ﹤0.01%
83,000
+22,500
+37% +$60.7K
CADL icon
1175
Candel Therapeutics
CADL
$775M
$167K ﹤0.01%
132,595
-105
-0.1% -$155

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.